The Harms of Psychedelics Need to Be Put Into Context
[ad_1] In November 2021, when the psychedelics company Compass Pathways released the top-line results of its trial looking at psilocybin in patients with treatment-resistant depression, the stock of the company…
Is the Psychedelic Therapy Bubble About to Burst?
[ad_1] In April 2021, a widely anticipated paper in the field of psychedelics dropped. The study, a small trial run at Imperial College London and published in The New England…
The High-Stakes Race to Engineer New Psychedelic Drugs
[ad_1] “This is my life,” Wallach says. “There is nothing else I’d rather be doing. If I was given a billion dollars, today, the first thing I would do is…